1 Introduction to Research & Analysis Reports
    1.1 Antivirals Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Antivirals Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Antivirals Overall Market Size
    2.1 Global Antivirals Market Size: 2021 VS 2027
    2.2 Global Antivirals Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Antivirals Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Antivirals Players in Global Market
    3.2 Top Global Antivirals Companies Ranked by Revenue
    3.3 Global Antivirals Revenue by Companies
    3.4 Global Antivirals Sales by Companies
    3.5 Global Antivirals Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Antivirals Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Antivirals Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Antivirals Players in Global Market
        3.8.1 List of Global Tier 1 Antivirals Companies
        3.8.2 List of Global Tier 2 and Tier 3 Antivirals Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Antivirals Market Size Markets, 2021 & 2027
        4.1.2 Generic
        4.1.3 Branded
    4.2 By Type - Global Antivirals Revenue & Forecasts
        4.2.1 By Type - Global Antivirals Revenue, 2016-2021
        4.2.2 By Type - Global Antivirals Revenue, 2022-2027
        4.2.3 By Type - Global Antivirals Revenue Market Share, 2016-2027
    4.3 By Type - Global Antivirals Sales & Forecasts
        4.3.1 By Type - Global Antivirals Sales, 2016-2021
        4.3.2 By Type - Global Antivirals Sales, 2022-2027
        4.3.3 By Type - Global Antivirals Sales Market Share, 2016-2027
    4.4 By Type - Global Antivirals Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Antivirals Market Size, 2021 & 2027
        5.1.2 HIV
        5.1.3 Hepatitis
        5.1.4 HSV
        5.1.5 Influenza
    5.2 By Application - Global Antivirals Revenue & Forecasts
        5.2.1 By Application - Global Antivirals Revenue, 2016-2021
        5.2.2 By Application - Global Antivirals Revenue, 2022-2027
        5.2.3 By Application - Global Antivirals Revenue Market Share, 2016-2027
    5.3 By Application - Global Antivirals Sales & Forecasts
        5.3.1 By Application - Global Antivirals Sales, 2016-2021
        5.3.2 By Application - Global Antivirals Sales, 2022-2027
        5.3.3 By Application - Global Antivirals Sales Market Share, 2016-2027
    5.4 By Application - Global Antivirals Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Antivirals Market Size, 2021 & 2027
    6.2 By Region - Global Antivirals Revenue & Forecasts
        6.2.1 By Region - Global Antivirals Revenue, 2016-2021
        6.2.2 By Region - Global Antivirals Revenue, 2022-2027
        6.2.3 By Region - Global Antivirals Revenue Market Share, 2016-2027
    6.3 By Region - Global Antivirals Sales & Forecasts
        6.3.1 By Region - Global Antivirals Sales, 2016-2021
        6.3.2 By Region - Global Antivirals Sales, 2022-2027
        6.3.3 By Region - Global Antivirals Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Antivirals Revenue, 2016-2027
        6.4.2 By Country - North America Antivirals Sales, 2016-2027
        6.4.3 US Antivirals Market Size, 2016-2027
        6.4.4 Canada Antivirals Market Size, 2016-2027
        6.4.5 Mexico Antivirals Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Antivirals Revenue, 2016-2027
        6.5.2 By Country - Europe Antivirals Sales, 2016-2027
        6.5.3 Germany Antivirals Market Size, 2016-2027
        6.5.4 France Antivirals Market Size, 2016-2027
        6.5.5 U.K. Antivirals Market Size, 2016-2027
        6.5.6 Italy Antivirals Market Size, 2016-2027
        6.5.7 Russia Antivirals Market Size, 2016-2027
        6.5.8 Nordic Countries Antivirals Market Size, 2016-2027
        6.5.9 Benelux Antivirals Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Antivirals Revenue, 2016-2027
        6.6.2 By Region - Asia Antivirals Sales, 2016-2027
        6.6.3 China Antivirals Market Size, 2016-2027
        6.6.4 Japan Antivirals Market Size, 2016-2027
        6.6.5 South Korea Antivirals Market Size, 2016-2027
        6.6.6 Southeast Asia Antivirals Market Size, 2016-2027
        6.6.7 India Antivirals Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Antivirals Revenue, 2016-2027
        6.7.2 By Country - South America Antivirals Sales, 2016-2027
        6.7.3 Brazil Antivirals Market Size, 2016-2027
        6.7.4 Argentina Antivirals Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Antivirals Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Antivirals Sales, 2016-2027
        6.8.3 Turkey Antivirals Market Size, 2016-2027
        6.8.4 Israel Antivirals Market Size, 2016-2027
        6.8.5 Saudi Arabia Antivirals Market Size, 2016-2027
        6.8.6 UAE Antivirals Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Merck
        7.1.1 Merck Corporate Summary
        7.1.2 Merck Business Overview
        7.1.3 Merck Antivirals Major Product Offerings
        7.1.4 Merck Antivirals Sales and Revenue in Global (2016-2021)
        7.1.5 Merck Key News
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Corporate Summary
        7.2.2 Johnson & Johnson Business Overview
        7.2.3 Johnson & Johnson Antivirals Major Product Offerings
        7.2.4 Johnson & Johnson Antivirals Sales and Revenue in Global (2016-2021)
        7.2.5 Johnson & Johnson Key News
    7.3 Teva Pharmaceutical Industries
        7.3.1 Teva Pharmaceutical Industries Corporate Summary
        7.3.2 Teva Pharmaceutical Industries Business Overview
        7.3.3 Teva Pharmaceutical Industries Antivirals Major Product Offerings
        7.3.4 Teva Pharmaceutical Industries Antivirals Sales and Revenue in Global (2016-2021)
        7.3.5 Teva Pharmaceutical Industries Key News
    7.4 GSK
        7.4.1 GSK Corporate Summary
        7.4.2 GSK Business Overview
        7.4.3 GSK Antivirals Major Product Offerings
        7.4.4 GSK Antivirals Sales and Revenue in Global (2016-2021)
        7.4.5 GSK Key News
    7.5 Mylan
        7.5.1 Mylan Corporate Summary
        7.5.2 Mylan Business Overview
        7.5.3 Mylan Antivirals Major Product Offerings
        7.5.4 Mylan Antivirals Sales and Revenue in Global (2016-2021)
        7.5.5 Mylan Key News
    7.6 Gilead Sciences
        7.6.1 Gilead Sciences Corporate Summary
        7.6.2 Gilead Sciences Business Overview
        7.6.3 Gilead Sciences Antivirals Major Product Offerings
        7.6.4 Gilead Sciences Antivirals Sales and Revenue in Global (2016-2021)
        7.6.5 Gilead Sciences Key News
    7.7 F. Hoffmann-La Roche
        7.7.1 F. Hoffmann-La Roche Corporate Summary
        7.7.2 F. Hoffmann-La Roche Business Overview
        7.7.3 F. Hoffmann-La Roche Antivirals Major Product Offerings
        7.4.4 F. Hoffmann-La Roche Antivirals Sales and Revenue in Global (2016-2021)
        7.7.5 F. Hoffmann-La Roche Key News
    7.8 Bristol-Myers-Squibb
        7.8.1 Bristol-Myers-Squibb Corporate Summary
        7.8.2 Bristol-Myers-Squibb Business Overview
        7.8.3 Bristol-Myers-Squibb Antivirals Major Product Offerings
        7.8.4 Bristol-Myers-Squibb Antivirals Sales and Revenue in Global (2016-2021)
        7.8.5 Bristol-Myers-Squibb Key News
    7.9 AbbVie
        7.9.1 AbbVie Corporate Summary
        7.9.2 AbbVie Business Overview
        7.9.3 AbbVie Antivirals Major Product Offerings
        7.9.4 AbbVie Antivirals Sales and Revenue in Global (2016-2021)
        7.9.5 AbbVie Key News
    7.10 Aurobindo Pharma
        7.10.1 Aurobindo Pharma Corporate Summary
        7.10.2 Aurobindo Pharma Business Overview
        7.10.3 Aurobindo Pharma Antivirals Major Product Offerings
        7.10.4 Aurobindo Pharma Antivirals Sales and Revenue in Global (2016-2021)
        7.10.5 Aurobindo Pharma Key News
    7.11 Cipla
        7.11.1 Cipla Corporate Summary
        7.11.2 Cipla Antivirals Business Overview
        7.11.3 Cipla Antivirals Major Product Offerings
        7.11.4 Cipla Antivirals Sales and Revenue in Global (2016-2021)
        7.11.5 Cipla Key News
    7.12 Dr Reddy’s
        7.12.1 Dr Reddy’s Corporate Summary
        7.12.2 Dr Reddy’s Antivirals Business Overview
        7.12.3 Dr Reddy’s Antivirals Major Product Offerings
        7.12.4 Dr Reddy’s Antivirals Sales and Revenue in Global (2016-2021)
        7.12.5 Dr Reddy’s Key News
8 Global Antivirals Production Capacity, Analysis
    8.1 Global Antivirals Production Capacity, 2016-2027
    8.2 Antivirals Production Capacity of Key Manufacturers in Global Market
    8.3 Global Antivirals Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Antivirals Supply Chain Analysis
    10.1 Antivirals Industry Value Chain
    10.2 Antivirals Upstream Market
    10.3 Antivirals Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Antivirals Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer